Menon, Poornima Jayadev http://orcid.org/0000-0003-0739-3313
Sambin, Sara
Criniere-Boizet, Baptiste
Courtin, Thomas
Tesson, Christelle
Casse, Fanny
Ferrien, Melanie
Mariani, Louise-Laure
Carvalho, Stephanie
Lejeune, Francois-Xavier
Rebbah, Sana
Martet, Gaspard
Houot, Marion
Lanore, Aymeric
Mangone, Graziella http://orcid.org/0000-0002-2847-3067
Roze, Emmanuel
Vidailhet, Marie
Aasly, Jan
Gan Or, Ziv http://orcid.org/0000-0003-0332-234X
Yu, Eric http://orcid.org/0000-0003-3525-4564
Dauvilliers, Yves
Zimprich, Alexander
Tomantschger, Volker
Pirker, Walter
Álvarez, Ignacio http://orcid.org/0000-0002-8537-3935
Pastor, Pau http://orcid.org/0000-0002-7493-8777
Di Fonzo, Alessio http://orcid.org/0000-0001-6478-026X
Bhatia, Kailash P.
Magrinelli, Francesca http://orcid.org/0000-0003-4706-6245
Houlden, Henry http://orcid.org/0000-0002-2866-7777
Real, Raquel http://orcid.org/0000-0001-8117-742X
Quattrone, Andrea http://orcid.org/0000-0003-2071-2083
Limousin, Patricia
Korlipara, Prasad
Foltynie, Thomas http://orcid.org/0000-0003-0752-1813
Grosset, Donald
Williams, Nigel
Narendra, Derek http://orcid.org/0000-0002-8696-9108
Lin, Hsin-Pin http://orcid.org/0000-0001-5320-2579
Jovanovic, Carna
Svetel, Marina
Lynch, Timothy
Gallagher, Amy http://orcid.org/0000-0003-2068-5628
Vandenberghe, Wim http://orcid.org/0000-0002-9758-5062
Gasser, Thomas http://orcid.org/0000-0002-1069-1146
Brockmann, Kathrin http://orcid.org/0000-0002-7515-8596
Morris, Huw R. http://orcid.org/0000-0002-5473-3774
Borsche, Max http://orcid.org/0000-0002-9651-5986
Klein, Christine http://orcid.org/0000-0003-2102-3431
Corti, Olga http://orcid.org/0000-0003-2093-7389
Brice, Alexis
Lesage, Suzanne
Corvol, Jean Christophe http://orcid.org/0000-0001-7325-0199
,
Article History
Received: 26 June 2023
Accepted: 7 March 2024
First Online: 29 March 2024
Competing interests
: A.D.F. received honoraria for participating as scientifica board member to advisory board from Sanofi, Bial, Zambon. H.M. is employed by UCL. In the last 12 months he reports paid consultancy from Roche, Aprinoia and Amylyx; lecture fees/honoraria—BMJ, Kyowa Kirin, Movement Disorders Society. Research Grants from Parkinson’s UK, Cure Parkinson’s Trust, PSP Association, Medical Research Council, Michael J Fox Foundation. H.W.M. is a co-applicant on a patent application related to C9ORF72—Method for diagnosing a neurodegenerative disease (PCT/GB2012/052140). Z.G. Or received consultancy fees from Lysosomal Therapeutics Inc. (LTI), Idorsia, Prevail Therapeutics, Inceptions Sciences (now Ventus), Ono Therapeutics, Bial Biotech, Bial, Handl Therapeutics, UCB, Capsida, Denali Lighthouse, Guidepoint and Deerfield. E.R. was supported by Société Française de Médecine esthétique and Enjoysharing for his work on Parkinson disease. Jean-Christophe Corvol has served in advisory boards for Alzprotect, Bayer, Biogen, Denali, Ferrer, Idorsia, Prevail Therapeutic, Servier, Theranexus, UCB; and received grants from Sanofi. Kailash P. Bhatia has received grant support from Wellcome/MRC, NIHR, Parkinson’s UK and EU Horizon 2020. He receives royalties from the publication of the Oxford Specialist Handbook Parkinson’s Disease and Other Movement Disorders (Oxford University Press, 2008), of Marsden’s Book of Movement Disorders (Oxford University Press, 2012), and of Case Studies in Movement Disorders—Common and uncommon presentations (Cambridge University Press, 2017). He has received honoraria/personal compensation for participating as consultant/scientific board member from Ipsen, Allergan, Merz and honoraria for speaking at meetings and from Allergan, Ipsen, Merz, Sun Pharma, Teva, UCB Pharmaceuticals and from the American Academy of Neurology and the International Parkinson’s Disease and Movement Disorders Society. H.H. is grateful for the essential support from patients and families and for grateful funding from The Wellcome Trust, The MRC, The MSA Trust, The National Institute for Health Research University College London Hospitals Biomedical Research Centre, The Michael J Fox Foundation (MJFF), BBSRC, The Fidelity Trust, Rosetrees Trust, Ataxia UK, Brain Research UK, Sparks GOSH Charity, Alzheimer’s Research UK (ARUK) and CureDRPLA. D.N. has a research collaboration with Spark Therapeutics for which he receives research funding support. M.B. received honoraria from Ipsen Pharma. L.-L.M. has received research support grants from INSERM, JNLF, The L’Oreal Foundation, the French Parkinson Association, Fondation of France, Paris Brain Institute BBT and Neurocatalyst calls; speech honoraria from CSL, Sanofi-Genzyme, Lundbeck, Teva; consultant for Accure therapeutics, Sanofi and received travel funding from the Movement Disorders Society, ANAINF, Merck, Merz, Medtronic, Teva and AbbVie, outside the submitted work. All other authors declare no financial or non-financial competing interest.